Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(6S,9S,12R,17R,20S,23S,25aS,31S,34S,37S,40S,43R,45aS,50aS,55R)-31,34-bis(2-amino-2-oxoethyl)-55-(2-aminoacetamido)-23-(carboxymethyl)-9-(hydroxymethyl)-6-isobutyl-37,40-dimethyl-5,8,11,19,22,25,30,33,36,39,42,45,50,56-tetradecaoxo-20-(4-(sulfooxy)benzyl)hexatetracontahydro-1H,5H-12,43-(epiminopropanodithiomethano)tripyrrolo[2,1-e1:2',1'-h1:2'',1''-m][1,2]dithia[5,8,11,14,17,20,23,26,29,32,35,38,41]tridecaazacyclotetratetracontine-17-carboxylic acid
ID: ALA5180647
PubChem CID: 168277138
Max Phase: Preclinical
Molecular Formula: C65H94N18O26S5
Molecular Weight: 1703.90
Associated Items: